SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Lithium Americas Corp. engages in the development of the Thacker Pass project. It is focused on advancing Thacker Pass to production it is located in northern Nevada. The company was founded on January 23, 2023 and is headquartered in Vancouver, Canada.

Lithium Americas Corp (NewCo)

Lithium Americas Corp

Lithium Americas Corp is trending due to news of a potential U.S. government stake in the company, fueling speculation of a short squeeze and long-term growth. Community members are actively discussing potential price targets and the significance of securing domestic lithium supply chains. The focus remains on the implications for national security and the electric vehicle market.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending due to recent news of BlueBird 6 completing assembly and its upcoming transport to India, sparking enthusiasm for potential launches; this buzz has ignited bullish sentiment among investors who anticipate a short squeeze, while also fueling debates around the company's marketing claims and competitive landscape with Starlink.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending amid discussions surrounding its recent earnings report, with the community debating whether the results justify the stock's performance. While some highlight the company's turnaround and potential for growth under its new CEO, others express concerns about tariff headwinds and decreasing margins. Community members are closely watching for upgrades and potential movement above key resistance levels.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

Traders are actively discussing $PYPL's price action, particularly a recent after-hours dip and its struggle to sustain gains, despite positive news and a Google partnership; some speculate about market manipulation and large entities impacting the stock. Community sentiment is mixed, with some expressing frustration over perceived underperformance and others seeing it as an undervalued opportunity, especially given the buyback program and the growth of PYUSD.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending after announcing a deal to acquire Metsera, a company focused on developing treatments for obesity, signaling a renewed push into the weight loss market. Community discussions revolve around the deal's potential impact on Pfizer's growth and its competitive positioning against other players in the sector. Some traders are speculating about potential follow-on effects for other companies in the weight loss space.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending as the community discusses Elon Musk canceling his subscription and a potential tariff on foreign films. Some traders are pointing to unusual options activity, while others are debating the impact of political ideologies on the platform. The stock's price movement and potential support levels are also being closely watched.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community anticipates potential ETF approvals, fueling excitement and bullish sentiment. Traders are closely watching key metrics and potential breakout points, while also exploring various meme coins and ecosystem projects built on Solana. Community members highlight the consistent growth, solid volume, and strong communities as reasons to keep $SOL.X on their radar.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MLTX is trending as the community discusses a potential overreaction to recent clinical trial results and the possibility of a future acquisition, with some citing a previous buyout offer. Talk centers around the stock's potential for a significant rebound, driven by its pipeline and cash reserves, despite the recent volatility. The community is closely watching for any news or PR from the company addressing the stock price and future plans.

Trump is back, crypto is booming, and Solana leads the charge! Welcome to Pump Trump, the memecoin inspired by the return of Donald J. Trump as President of the United States. With Trump back in office, his bold vision for innovation and economic dominance extends to the crypto market – and we're here to ride that wave to the moon! Built on the Solana blockchain, Pump Trump combines the speed, efficiency, and scalability of Solana with the hype and energy of a true memecoin revolution. Trump's pro- business stance and his focus on shaking up the system mean one thing: crypto is about to pump harder than ever! It's time to Make America Great Again, and with Pump Trump on Solana, we're creating a new financial frontier for everyone.

PUMP TRUMP

PUMPTRUMP.X is trending as social media mentions and community enthusiasm drive speculation about a potential surge. Comparisons to other popular cryptocurrencies like SOL, BTC, and PEPE are fueling discussions, with many expressing bullish sentiment and anticipating upward movement.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending as investors react to the looming government shutdown and its potential impacts, with community members weighing in on whether the market will rally or decline. Discussions include the possibility of delayed economic data releases and potential credit downgrades should the shutdown be prolonged. Some traders believe that the risk of a shutdown is already priced in, while others anticipate a significant market correction.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CYDY Did LL cure Acinetobacter baumannii during covid... 
 
From a Covid report: Respiratory tract infections were the most common during ECMO treatment, and the main pathogen was Acinetobacter baumannii. 
 
CDC: Acinetobacter baumannii can cause infections in the blood, urinary tract, lungs (pneumonia) or wounds. 
 
Leronlimab was the only drug in the world that took very long term covid people off ECMO @ 14 days &amp; here&#39;s just 1 other: 
https://pmc.ncbi.nlm.nih.gov/articles/PMC7985604/ 
 
Risk factors for A. baumannii infection include admission to the ICU, advanced age, immunosuppression, intravascular devices, invasive procedures, malignancies, mechanical ventilation, prior colonization, prolonged hospital stay, recent surgery, and severity of illness&quot; 
 
Leronlimab definitely checks a few of those boxes.

Clark Kent

Steven feldman

Paul Steele

Jerry

vivamiga

James McNeal

The number of confirmed cases of infection with SARS-CoV-2, the virus causing Coronavirus disease 2019 (COVID-19), continues to increase and is associated with substantial morbidity and mortality in virtually every country in the world. Although in ...

PubMed Central (PMC)

Case study of a critically ill person with COVID-19 on ECMO successfully treated with leronlimab

StockTwits Web

CytoDyn Inc

 Did LL cure Acinetobacter baumannii during covid... 
 
From a Covid report: Respiratory tract infections were the most common during ECMO treatment, and the main pathogen was Acinetobacter baumannii. 
 
CDC: Acinetobacter baumannii can cause infections in the blood, urinary tract, lungs (pneumonia) or wounds. 
 
Leronlimab was the only drug in the world that took very long term covid people off ECMO @ 14 days & here's just 1 other: 


 
 
Risk factors for A. baumannii infection include admission to the ICU, advanced age, immunosuppression, intravascular devices, invasive procedures, malignancies, mechanical ventilation, prior colonization, prolonged hospital stay, recent surgery, and severity of illness" 
 
Leronlimab definitely checks a few of those boxes.

christopher

Cytodyn March 09, 2020: “Coronavirus deaths are linked to patients’ immune systems that have an inflammatory response to the virus causing Acute Respiratory Distress Syndrome (ARDS). With ARDS, the entire lung is affected, unlike pneumonia where often only part of the lung is affected,” --- Aka: our cytokine storm blitz from back then. 
 
Acinetobacter baumannii is a leading cause of hospital-acquired infections (HAIs), particularly in intensive care units (ICUs), and is associated with high mortality rates. 
 
Antimicrobial Resistance: 
A major concern is the increasing prevalence of multidrug-resistant A. baumannii (MDR-AB) and carbapenem-resistant A. baumannii (CRAB), which makes infections difficult to treat. 
 
Mortality Rates: 
Studies have shown that mortality rates can be as high as 35% to 84.3% in patients with MDR-AB infections, especially those in ICUs.

In a study, the 30-day mortality rate associated with A. baumannii infection was 71.2%. 
 
In another study, 14-day mortality was observed in 26.1% of patients and 30-day mortality in 30.9% of the patients. 
 
Odds are Leronlimab also defeated Acinetobacter baumannii pneumonia during covid. With Ab being the fastest mortality rate Leronlimab has defeated to date. 
 
Diagnosed with Acinetobacter baumannii: 
 
Leronlimab combo for Acinetobacter baumannii to see if can help in the Antimicrobial Resistance fight. 
 
Just like with chemo.